Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiguo Luo

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
Colloids and Surfaces. B, Biointerfaces|June 2, 2026
Co-dispersion-mediated stabilization of a poorly soluble palmitoylation inhibitor within an alginate hydrogel for localized ferroptosis therapyLi Shen, Han Zhang, Yuanyuan Li, et al.
International Journal of Oncology|March 24, 2018
Ethoxysanguinarine inhibits viability and induces apoptosis of colorectal cancer cells by inhibiting CIP2ALan Jin, Yuan Si, Xing Hong, et al.
Oncotarget|April 30, 2016
Thalidomide enhanced the efficacy of CHOP chemotherapy in the treatment of diffuse large B cell lymphoma: A phase II studyDongmei Ji, Qiu Li, Junning Cao, et al.
Cancer Medicine|July 6, 2023
Clinical features and prognosis of patients with metastatic ocular and orbital melanoma: A bi-institutional studyXin Liu, Han Yue, Shiyu Jiang, et al.
BMC Medicine|January 4, 2023
First-in-human phase I dose-escalation and dose-expansion trial of the selective MEK inhibitor HL-085 in patients with advanced melanoma harboring NRAS mutationsXuan Wang, Zhiguo Luo, Jing Chen, et al.
BMC Cancer|July 11, 2020
Sentinel node theory helps tracking of primary lesions of cancers of unknown primaryYilin Shao, Xin Liu, Silong Hu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|June 4, 2019
Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer: A phase II open-label clinical studyShanshan Qin, Hui Yu, Xianghua Wu, et al.
Science China. Life Sciences|March 7, 2026
Targeting methionine-induced pyroptosis enhances anti-tumor immunityMingzhu Lei, Wenying Zhu, Chao Wang, et al.
Cancer|November 2, 2020
Association between recent oncologic treatment and mortality among patients with carcinoma who are hospitalized with COVID-19: A multicenter studyKehan Song, Hongyun Gong, Bin Xu, et al.
Cellular Signalling|October 19, 2024
GALNT14-mediated O-glycosylation drives lung adenocarcinoma progression by reducing endogenous reactive oxygen species generationBingbing Tang, Kelong Wang, Qiulei Ren, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Colloids and Surfaces. B, Biointerfaces|June 2, 2026
Co-dispersion-mediated stabilization of a poorly soluble palmitoylation inhibitor within an alginate hydrogel for localized ferroptosis therapyLi Shen, Han Zhang, Yuanyuan Li, et al.
International Journal of Oncology|March 24, 2018
Ethoxysanguinarine inhibits viability and induces apoptosis of colorectal cancer cells by inhibiting CIP2ALan Jin, Yuan Si, Xing Hong, et al.
Oncotarget|April 30, 2016
Thalidomide enhanced the efficacy of CHOP chemotherapy in the treatment of diffuse large B cell lymphoma: A phase II studyDongmei Ji, Qiu Li, Junning Cao, et al.
Cancer Medicine|July 6, 2023
Clinical features and prognosis of patients with metastatic ocular and orbital melanoma: A bi-institutional studyXin Liu, Han Yue, Shiyu Jiang, et al.
BMC Medicine|January 4, 2023
First-in-human phase I dose-escalation and dose-expansion trial of the selective MEK inhibitor HL-085 in patients with advanced melanoma harboring NRAS mutationsXuan Wang, Zhiguo Luo, Jing Chen, et al.
BMC Cancer|July 11, 2020
Sentinel node theory helps tracking of primary lesions of cancers of unknown primaryYilin Shao, Xin Liu, Silong Hu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|June 4, 2019
Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer: A phase II open-label clinical studyShanshan Qin, Hui Yu, Xianghua Wu, et al.
Science China. Life Sciences|March 7, 2026
Targeting methionine-induced pyroptosis enhances anti-tumor immunityMingzhu Lei, Wenying Zhu, Chao Wang, et al.
Cancer|November 2, 2020
Association between recent oncologic treatment and mortality among patients with carcinoma who are hospitalized with COVID-19: A multicenter studyKehan Song, Hongyun Gong, Bin Xu, et al.
Cellular Signalling|October 19, 2024
GALNT14-mediated O-glycosylation drives lung adenocarcinoma progression by reducing endogenous reactive oxygen species generationBingbing Tang, Kelong Wang, Qiulei Ren, et al.
Pageof 13